News | News By Subject | News by Disease News By Date | Search News

Tuberculosis News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Novartis AG (NVS)'s Afinitor Significantly Reduces Seizures in TSC Patients in Late Stage Study     4/21/2016
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Sanofi (SAN.PA) Gets U.S. Approval For Use Of Priftin Drug In Latent TB     12/2/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Novartis AG (NVS), Global Alliance For TB Drug Development Link Up To Search For TB Cure     8/20/2014
European Medicines Agency Postpones Decision On Teva Pharmaceutical Industries Limited (TEVA)'s MS Pill Laquinimod     12/23/2013
Pfizer Inc. (PFE)'s Drug to Treat Tuberculosis in Short Supply     3/27/2013
Aeras/Oxford University Development of TB Vaccine Hits Snag     2/5/2013
FDA Approves Johnson & Johnson (JNJ) TB Drug; First in 40 Years     1/7/2013
Will FDA Grant Accelerated Approval to Johnson & Johnson (JNJ) TB Drug?     12/28/2012
FDA Says Johnson & Johnson (JNJ)'s TB Drug Appears Safe     11/27/2012
FDA Sets Johnson & Johnson (JNJ)'s TB Drug on Accelerated Path to Approval     9/7/2012
Johnson & Johnson (JNJ) Seeks Approval for Resistant TB Drug     7/3/2012
Sanofi Pasteur (SASY.PA) Recalls Tuberculosis Vaccine Over Contamination Concerns     6/18/2012
Otsuka Pharmaceutical Co., Ltd.'s Experimental TB Drug Fights Resistant Disease     6/8/2012

News from Around the Web
Pepsi To Test New Flavors For Tuberculosis Drugs     11/4/2016
Rapid Test For Tuberculosis Developed, Texas A&M University Study     10/20/2016
Without Success in India, We'll Never Control Drug-Resistant Tuberculosis Anywhere     8/26/2016
Diagnostics Breakthrough To Tackle TB Developed, Cambridge Consultants Reveals     7/13/2016
Rapid Finger-Prick Test To Tackle Tuberculosis, Stellenbosch University Study     5/17/2016
Giant Rats In African Prisons Take A Crack At Disease Prevention By Sniffing Out Tuberculosis     4/11/2016
Tuberculosis Kills Thousands Of People Every Day -- We Aren't Doing Enough To Stop It     3/30/2016
Curcumin May Help Overcome Drug-Resistant Tuberculosis, University of Colorado Study     3/25/2016
Innovative Blood Test To Predict Tuberculosis Risk Developed, Center For Infectious Disease Research Researchers Reveal     3/25/2016
India Will Soon Have A Cheaper, Indigenous Diagnostic Tool For TB     3/9/2016
Blood Test Could Transform Tuberculosis Diagnosis, Help Monitor Treatment Effectiveness, Stanford University School of Medicine Reveals     2/22/2016
Plant-Based Drug Can Fight Resistant TB, The Scripps Research Institute Study     12/21/2015
On-Chip Processor The First Step In Point-Of-Care Asthma And TB Diagnostics, Penn State University Study     8/3/2015
2-Pound DNA-Reader Could Help Fight Ebola, TB, HIV     7/30/2015
Diabetes, TB Link Discovered, James Cook University Study     7/28/2015

Press Releases
Tests Decrease Waiting Time For Drug-Resistant TB Patients, European Respiratory Society Reveals     9/8/2016
Cincinnati Children's Hospital Medical Center Release: Drug Reduces Seizure Frequency In Children With Tuberous Sclerosis Complex     9/7/2016
Longhorn Vaccines & Diagnostics LLC Announces PrimeStore Molecular Transport Medium Significantly Improves Cepheid Xpert MTB/RIF Sensitivity In Crucial Low Copy Samples     7/18/2016
NYU Langone Medical Center Release: Tuberculosis Bacteria Build "Edible" Havens In Immune Cells     4/18/2016
Tuberculosis Study Launched, Powered By Citizen Scientists On IBM (IBM)'s World Community Grid     3/24/2016
USAID And Cepheid (CPHD) Plan Collaboration To Accelerate Global Diagnosis Of Multidrug-Resistant Tuberculosis     1/7/2016
Avisa’s Biomarker Breath Test Detects Tuberculosis In South Africa Pilot Study     12/21/2015
FIND And Cepheid (CPHD) Announce A Strategic Collaboration To Advance Point-Of-Care TB Diagnosis     12/3/2015
TB Alliance And Partners Announce World's First Availability Of Appropriate, Child-Friendly TB Medicines In Correct Doses     12/2/2015
Center for Infectious Disease Research-GlaxoSmithKline (GSK) Partnership Identifies Potential For New Tuberculosis Treatments     10/13/2015
Infectious Disease Research Institute (IDRI) And Wellcome Trust Team For Tuberculosis Vaccine Trial In South Africa     9/17/2015
Lakewood-Amedex Inc. Announces Its Novel Bisphospocin Class Of Antimicrobials Kills Multidrug Resistant-Tuberculosis (MDR-TB) Strains In Fifteen Minutes     5/19/2015
Australia Grants Support For TB Alliance To Advance New TB Drugs     3/25/2015
TB Alliance Announces Partnership With U.S. Fund For UNICEF To Increase Access To Impending New Child-Friendly TB Treatments     3/24/2015
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine     11/20/2014

//-->